Screening for Barrett's Esophagus in Otolaryngology Patients - Full Text View

Sponsor:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:	NCT00695227

Purpose

The purpose of this project is to develop an accurate method to identify patients that suffer from acid reflux, but may not present with classic reflux symptoms (such as heart burn). Additionally, it is the purpose of this project to utilize the Unsedated Small-caliber Endoscopy (USE) to assess the prevalence of Barrett's esophagus in a population of patients with laryngopharyngeal reflux (LPR) symptoms and to define normal patterns of LPR. Laryngopharyngeal reflux (LPR) is when a small amount of stomach contents and acid are pushed up through the esophagus and may affect the vocal cords and upper respiratory tract.

It is suspected that patients with LPR symptoms may have a prevalence of Barrett's esophagus similar to that found in a population with typical reflux symptoms. We propose to systematically test this hypothesis using the USE.

This project is designed to improve the methods of identifying patients with a form of acid reflux that is often undetected, and thus untreated. If this project is successful then more patients with Barrett's esophagus will be identified; furthermore, screening and treatment for this pre-cancerous condition will be improved.

Condition	Intervention	Phase
Extra Esophageal Symptoms: Cough Throat Clearing Hoarseness Difficulty Swallowing	Drug: Proton Pump Inhibitor	Phase II

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title:	Screening for Barrett's Esophagus in Otolaryngology Patients

Resource links provided by NLM:

MedlinePlus related topics: Cough Swallowing Disorders

U.S. FDA Resources

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:

The primary aim of the study is to establish that patients with symptoms of LPR who are referred to an otolaryngology clinic have a prevalence of Barrett's metaplasia equivalent to that of a population with GERD symptoms. [ Time Frame: One time ] [ Designated as safety issue: No ]

Estimated Enrollment:	500
Study Start Date:	May 2004
Estimated Study Completion Date:	November 2012
Estimated Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)

Intervention Details:

Screened patients with extraesophageal reflux symptoms will be followed prospectively in order to gauge response to acid suppressing medication treatment. Non-responders will be tested with pharyngeal pH monitoring.

Eligibility

Ages Eligible for Study:	18 Years to 90 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

-

Exclusion Criteria:

Prior anti-reflux surgery, laryngeal surgery, trauma to larynx Esophageal diverticulum Pregnancy Anticoagulation therapy Esophageal varices ENT malignancy History of recurrent epistaxis

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00695227

Locations

United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97239-3098

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

Principal Investigator:

Joshua Schindler, MD

Oregon Health and Science University

More Information

No publications provided

Responsible Party:	Oregon Health & Science University ( Joshua Schindler )
Study ID Numbers:	DK66165, DK066165-02
Study First Received:	June 6, 2008
Last Updated:	March 4, 2009
ClinicalTrials.gov Identifier:	NCT00695227 History of Changes
Health Authority:	United States: Food and Drug Administration; United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

laryngopharyngeal reflux
extraesophageal reflux symptoms

Additional relevant MeSH terms:

Otorhinolaryngologic Diseases
Molecular Mechanisms of Pharmacological Action
Gastrointestinal Diseases
Hoarseness
Nervous System Diseases
Respiration Disorders
Enzyme Inhibitors
Pharyngeal Diseases
Pharmacologic Actions
Deglutition Disorders
Signs and Symptoms

Digestive System Abnormalities
Digestive System Diseases
Proton Pump Inhibitors
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Neurologic Manifestations
Barrett Esophagus
Esophageal Diseases
Voice Disorders
Laryngeal Diseases

ClinicalTrials.gov processed this record on November 22, 2009